Search
for
Sort by
Research 61–90 of 575
- Dutasteride for the treatment of benign prostatic hyperplasia
- 5α-Reductase: History and Clinical Importance
- Development of a new gas chromatography–mass spectrometry (GC–MS) methodology for the evaluation of 5α-reductase activity
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Shedding Light on the Effects of Calorie Restriction and Its Mimetics on Skin Biology
- The role of 5-alpha-reductase inhibitors in active surveillance
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- Smart Fluids As Autophagy-Activating Photoprotectors: In Vitro Analysis of Dead Sea Water and Magnetized Saline Water Against Ultraviolet B (UVB)-Induced Photodamage in Human Keratinocytes
- PSA Test Sensitized by Finasteride
- Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico
- Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata
- Urological Oncology: Prostate Cancer
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- C-2-3 GND-VIAを用いたX帯SiGe-MMIC増幅器(C-2. マイクロ波A(能動デバイス), エレクトロニクス1)
- 5 Alpha-reductase inhibitors: whatʼs new?
- Phytochemical and pharmacological properties of Jatropha dioica
- Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro
- Potential of nano-phytochemicals in cervical cancer therapy
- Management of Advanced Prostate Cancer Undergoing Major Shift
- Effect of non-steroidal anti-inflammatory drugs on post-surgical complications against the backdrop of the opioid crisis
- S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER?
- S2 PSA: RELIABLE OR NOT RELIABLE?
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Resveratrol derivatives: a patent review (2009 – 2012)
- Clinical use of 5α-reductase inhibitors